home / stock / cytk / cytk articles

CYTK Articles, Cytokinetics Incorporated - From 03/25/24

Stock Information
Company Name: Cytokinetics Incorporated
Stock Symbol: CYTK
Market: NASDAQ
Website: cytokinetics.com
Menu
CYTK CYTK Quote CYTK Short CYTK News CYTK Articles CYTK Message Board
Get CYTK Alerts

News, Short Squeeze, Breakout and More Instantly...
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session | Benzinga

SOUTH SAN FRANCISCO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced four presentations at t...
Cytokinetics to Participate in March Investor Conferences | Benzinga

SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that the company is sch...

Here's How Much $1000 Invested In Cytokinetics 10 Years Ago Would Be Worth Today | Benzinga

Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 10 years by 12.46% on an annualized basis producing an average annual return o...

Cytokinetics to Announce Fourth Quarter Results on February 27, 2024 | Benzinga

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that it is scheduled to ...
Here's How Much $1000 Invested In Cytokinetics 5 Years Ago Would Be Worth Today | Benzinga

Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 5 years by 46.76% on an annualized basis producing an average annual return of...

Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference | Benzinga

SOUTH SAN FRANCISCO, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that Robert I. Blum, Pre...

Banco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session | Benzinga

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Monday. Shares of Banco Santander, S.A. (NYSE: SAN) sh...
Here's How Much $100 Invested In Cytokinetics 5 Years Ago Would Be Worth Today | Benzinga

Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 5 years by 48.59% on an annualized basis producing an average annual return of...

Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024 | Benzinga

SOUTH SAN FRANCISCO, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced an upcoming presentation...

Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst | Benzinga

Thursday, Novartis AG (NYSE:NVS) decided to step back from pursuing the Cytokinetics Inc (NASDAQ:CYTK) acquisition, dealin...
Previous 10 Next 10